A team from INST Mohali, NIPER Raebareli, and Gujarat Biotechnology University has pioneered a multifunctional nanoparticle-based therapy for Alzheimer’s, raising damaged brain cell survival from 40–50% to nearly 90%. Published in Small, the approach targets toxic protein buildup, inflammation, and brain repair, offering renewed hope for tackling this complex neurodegenerative disease.
